Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News What SL Bio’s Nasdaq debut reveals about biotech funding after the SPAC reset Find out how SL Bio’s Nasdaq listing could shape SLBT stock, off-the-shelf cell therapy and biotech SPAC sentiment today! bySoujanya RaviJune 15, 2026